Experimental drugs for fallopian cancer: promising agents in the clinical trials and key stumbling blocks for researchers
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2160313
Abstract: ABSTRACT Introduction Fallopian tube carcinoma (FC) as a single entity is a rare disease. Although its diagnosis is increasing thanks to the widespread use of prophylactic salpingectomy, there are no clinical trials exclusively designed for… read more here.
Keywords: clinical trials; cancer promising; drugs fallopian; fallopian cancer ... See more keywords